Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
10.53
-0.48 (-4.36%)
May 18, 2026, 3:38 PM EDT - Market open
Zevra Therapeutics Market Cap
Zevra Therapeutics has a market cap or net worth of $622.48 million as of May 18, 2026. Its market cap has increased by 50.58% in one year.
Market Cap
622.48M
Enterprise Value
433.65M
1-Year Change
50.58%
Ranking
Category
Stock Price
$10.53
Market Cap Chart
Since April 16, 2015, Zevra Therapeutics's market cap has increased from $137.80M to $622.48M, an increase of 351.73%. That is a compound annual growth rate of 14.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 650.90M | 29.04% |
| Dec 31, 2025 | 504.40M | 13.30% |
| Dec 31, 2024 | 445.20M | 87.69% |
| Dec 29, 2023 | 237.20M | 49.75% |
| Dec 30, 2022 | 158.40M | -48.50% |
| Dec 31, 2021 | 307.60M | 505.51% |
| Dec 31, 2020 | 50.80M | 303.17% |
| Dec 31, 2019 | 12.60M | -73.25% |
| Dec 31, 2018 | 47.10M | -20.71% |
| Dec 29, 2017 | 59.40M | 37.50% |
| Dec 30, 2016 | 43.20M | -84.95% |
| Dec 31, 2015 | 287.00M | 108.27% |
| Apr 16, 2015 | 137.80M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eikon Therapeutics | 717.34M |
| Tenax Therapeutics | 705.36M |
| Allogene Therapeutics | 690.31M |
| Solid Biosciences | 681.27M |
| BridgeBio Oncology Therapeutics | 681.08M |
| Crescent Biopharma | 663.58M |
| Sutro Biopharma | 645.65M |
| Candel Therapeutics | 642.58M |